Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related HPQ
Piper Jaffray Suspects HP Is Siphoning Off Demand From 3D Systems, Downgrades To Underweight
Slowdown In 3D Printing Demand Has Piper Jaffray Downgrading Stratasys
Hewlett Packard Enterprise Stock Spikes, Private Equity Buyout? (Investor's Business Daily)
Related HNZ
4 Potential Reasons Mondelez Bid For Hershey
McDonald's Returns To Chicago Searching For Millennials Despite City Troubles

Pre-open movers US stock futures are mostly flat this morning, as investors are awaiting housing starts data. Futures for the Dow Jones Industrial Average dropped 7 points to 12,731.00 and S&P 500 index futures rose 1 point to 1,383.50. Nasdaq 100 futures gained 3.50 points to 2,589.00.

A Peek Into Global Markets European markets were mostly lower today. The STOXX Europe 600 Index fell 0.20%, London's FTSE 100 Index dropped 0.19%, French CAC 40 Index declined 0.16% and German DAX 30 index rose 0.06%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average falling 0.12%, China's Shanghai Composite dropping 0.40% and Australia's S&P/ASX 200 rising 0.57%. Hong Kong's Hang Seng Index declined 0.16% India's Sensex fell 0.05%.

Broker Recommendation Analysts at Raymond James downgraded Hewlett-Packard Co (NYSE: HPQ) from “outperform” to “market perform.”

Hewlett-Packard shares dropped 6.92% to $12.38 in pre-market trading.

Breaking news

  • H.J. Heinz Co (NYSE: HNZ) reported a rise in its second-quarter profit. To read the full news, click here.
  • UGI (NYSE: UGI) today announced that its subsidiary, Flaga GmbH, has reached a definitive agreement to acquire the liquefied petroleum gas (LPG) distribution business of BP (NYSE: BP) in Poland. To read the full news, click here.
  • Kirkland's (NASDAQ: KIRK) today announced that Robert Alderson, the Company's President and Chief Executive Officer, will take a temporary medical leave of absence, effective November 26, 2012. To read the full news, click here.
  • Amarin Corporation plc (NASDAQ: AMRN) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering Amarin's Vascepa® (icosapent ethyl) capsules based on U.S. Patent Application Serial No. 13/284,408. To read the full news, click here.

Posted-In: Raymond James US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (AMRN + BP)

View Comments and Join the Discussion!